Switch Therapeutics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
241 E Harris Ave, South San Francisco, C...Website
www.switchthera.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Switch Therapeutics
Switch Therapeutics is developing biomarker-gated, genetic medicines to transform the treatment of disease. The company is based in South San Francisco, California.Explore more
Switch Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
MN
Senior Scientist
AR
Senior Scientist
CS
Research Associate II
PL
Scientist
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Switch Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if Switch Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Switch Therapeutics had a recent Job posting/layoffs
Check out if Switch Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Switch Therapeutics
Funding: Get notified immidiatlly once Switch Therapeutics has new funding data
Earning: See what the market has to say on Switch Therapeutics recently announced quarterly report
Product Launch: Get notified when Switch Therapeutics launches new products
Switch Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Switch Therapeutics
Compare insights from companies similar to Switch Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$9.1M
11-50
Private
$220M
2020
Mehrdad HamadaniChief Technology Officer & Executive VP, Engineering, Artificial Intelligence & Operations
Company Profile Activity
Activity Insights
Switch Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Switch Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Switch Therapeutics.
Switch Therapeutics financials insights
Gather financial insights about Switch Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$52M
Switch Therapeutics Tech Stack
A closer look at the technologies used by Switch Therapeutics
See more technologies
Most Recent Scoops
Person-Based
Person-Based
New Hire
Executive Move
Executive Moves, New Hire
Lateral Move
Executive Move
Executive Move
Board of Directors
Switch Therapeutics News & Media
Switch Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Switch Therapeutics announces Dee Datta, Ph.D., co-founder and CEO, will present and host investor meetings on Thursday, June 27, 2024.Switch Therapeutics to Present at Evercore ISI 2024 Emerging Biotech Conference
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Switch Therapeutics to present at Evercore ISI 2024 Emerging Biotech Conference on Thursday, February 29, 2024 at 1:05 p.m. ET.Switch Therapeutics Appoints Charles Allerson, Ph.D., as Chief Technology Officer
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Switch Therapeutics today announced the appointment of Charles Allerson, Ph.D., as Chief Technology Officer (CTO).Switch Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Switch Therapeutics announces Co-Founder and CEO, Dee Data, Ph.D., will present at the Morgan Stanley 21st Annual Global Healthcare Conference.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Switch Therapeutics
Sign Up For FreeTo access detailed company insights
Switch Therapeutics is developing biomarker-gated, genetic medicines to transform the treatment of disease. The company is based in South San Francisco, California.... Read More
